In light of the increased public health risks and the uncertainty in the underlying data, we see the need for improved monitoring of cannabis potency in Europe. The need for better data is further substantiated by changes in the cannabis market, such as the emergence of products containing high levels of cannabidiol in Europe [81] and the widespread use of highly concentrated cannabis extracts in North America.
